MA23194A1 - Procede pour la preparation de particules preparees a sec, particules preparees a sec ainsi obtenues et compositions pharmaceutiques contenant de telles particules . - Google Patents

Procede pour la preparation de particules preparees a sec, particules preparees a sec ainsi obtenues et compositions pharmaceutiques contenant de telles particules .

Info

Publication number
MA23194A1
MA23194A1 MA23503A MA23503A MA23194A1 MA 23194 A1 MA23194 A1 MA 23194A1 MA 23503 A MA23503 A MA 23503A MA 23503 A MA23503 A MA 23503A MA 23194 A1 MA23194 A1 MA 23194A1
Authority
MA
Morocco
Prior art keywords
particles
dry
prepared
preparation
pharmaceutical compositions
Prior art date
Application number
MA23503A
Other languages
English (en)
French (fr)
Inventor
Ruiz Jean-Marc
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of MA23194A1 publication Critical patent/MA23194A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
MA23503A 1993-05-15 1994-05-13 Procede pour la preparation de particules preparees a sec, particules preparees a sec ainsi obtenues et compositions pharmaceutiques contenant de telles particules . MA23194A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939310030A GB9310030D0 (en) 1993-05-15 1993-05-15 Dry processed particles and process for the preparation of the same

Publications (1)

Publication Number Publication Date
MA23194A1 true MA23194A1 (fr) 1994-12-31

Family

ID=10735537

Family Applications (1)

Application Number Title Priority Date Filing Date
MA23503A MA23194A1 (fr) 1993-05-15 1994-05-13 Procede pour la preparation de particules preparees a sec, particules preparees a sec ainsi obtenues et compositions pharmaceutiques contenant de telles particules .

Country Status (34)

Country Link
JP (1) JP3139913B2 (OSRAM)
KR (1) KR100341261B1 (OSRAM)
CN (1) CN1050534C (OSRAM)
AT (1) AT406017B (OSRAM)
AU (1) AU685094B2 (OSRAM)
BE (1) BE1008323A3 (OSRAM)
BR (1) BR9401968A (OSRAM)
CA (1) CA2123481C (OSRAM)
CH (1) CH688572A5 (OSRAM)
DE (1) DE4416812C2 (OSRAM)
DK (1) DK171454B1 (OSRAM)
DZ (1) DZ1779A1 (OSRAM)
ES (1) ES2097083B1 (OSRAM)
FI (1) FI112915B (OSRAM)
FR (1) FR2705232B1 (OSRAM)
GB (2) GB9310030D0 (OSRAM)
GR (1) GR1002034B (OSRAM)
HU (1) HU220617B1 (OSRAM)
IE (1) IE940392A1 (OSRAM)
IN (1) IN182330B (OSRAM)
IT (1) IT1269508B (OSRAM)
LU (1) LU88482A1 (OSRAM)
MA (1) MA23194A1 (OSRAM)
NL (1) NL9400795A (OSRAM)
NO (1) NO307403B1 (OSRAM)
NZ (1) NZ260520A (OSRAM)
OA (1) OA09939A (OSRAM)
PL (1) PL175780B1 (OSRAM)
PT (1) PT101518B (OSRAM)
RU (1) RU2125869C1 (OSRAM)
SE (1) SE519004C2 (OSRAM)
SG (1) SG46631A1 (OSRAM)
TN (1) TNSN94046A1 (OSRAM)
ZA (1) ZA943316B (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU220137B (hu) * 1993-01-06 2001-11-28 Kinerton Ltd. Biológiailag lebontható poliészterek és biológiailag aktív polipeptidek ionos molekuláris konjugátumai, eljárás ezek előállítására és eljárás mikrorészecskék előállítására
DE69435055T2 (de) * 1993-01-06 2008-12-04 IPSEN Manufacturing Ireland Ltd., Blanchardstown Bioabbaubare Polyester zur Herstellung ionischer molekularer Konjugate mit bioaktiven Polypeptiden
DE19604744A1 (de) 1996-02-09 1997-08-14 Henkel Kgaa Technische Di-/Triglyceridgemische
IE960308A1 (en) 1996-04-23 1997-11-05 Kinerton Ltd Sustained release ionic conjugate
DE19617137C1 (de) * 1996-04-29 1997-02-27 Henkel Kgaa Verwendung von Copolymerestern für die Herstellung von Mikrosphären
US5858531A (en) * 1996-10-24 1999-01-12 Bio Syntech Method for preparation of polymer microparticles free of organic solvent traces
US6867181B1 (en) 1997-06-02 2005-03-15 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
EP1183014B1 (en) * 1999-06-14 2003-10-08 Cosmo S.p.A. Controlled release and taste masking oral pharmaceutical compositions
CA2427938C (en) 1999-11-15 2010-02-16 Bio Syntech Canada Inc. Novel temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution, composition and preparation thereof
CA2350728A1 (en) * 2000-06-16 2001-12-16 Nippon Shokubai Co., Ltd. Crosslinked polmer, method for manufacturing it and use thereof
GB0705159D0 (en) * 2007-03-19 2007-04-25 Prosonix Ltd Process for making crystals

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH468192A (de) * 1964-06-19 1969-02-15 Ciba Geigy Verfahren zur Herstellung von Arzneimitteln in Perlenform
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
CH672887A5 (OSRAM) * 1987-10-14 1990-01-15 Debiopharm Sa
WO1989003678A1 (en) * 1987-10-30 1989-05-05 Stolle Research & Development Corporation Low residual solvent microspheres and microencapsulation process
DE3916020C2 (de) * 1989-05-17 1994-06-01 Burkhard Dr Wichert Retardierende Mikropartikel aus bioabbaubaren Polyestern; Verfahren zu deren Herstellung unter Verzicht auf toxische Lösungsmittel und diese Mikropartikel enthaltende pharmazentische Zubereitungen
EP0452145B1 (en) * 1990-04-12 1996-11-13 SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. Coated composition and its preparation process
JP3116311B2 (ja) * 1990-06-13 2000-12-11 エーザイ株式会社 マイクロスフィアの製法
GB9016885D0 (en) * 1990-08-01 1990-09-12 Scras Sustained release pharmaceutical compositions
GB2246514B (en) * 1990-08-01 1993-12-15 Scras Sustained release pharmaceutical compositions and the preparation of particles for use therein
SE9003296L (sv) * 1990-10-16 1992-04-17 Kabi Pharmacia Ab Foerfarande foer att formulera laekemedel
CA2055522A1 (en) * 1990-12-12 1992-06-13 Masako Andoh Microspheres for ophthalmic use
SE467815B (sv) * 1991-05-27 1992-09-21 Bengt Hjalmar Aagerup Med Firm Metod foer att framstaella reproducerbara partiklar av definierad storlek
GB9203689D0 (en) * 1992-02-20 1992-04-08 Euro Celtique Sa Pharmaceutical composition
CA2129514A1 (en) * 1992-03-12 1993-09-16 M. Amin Khan Controlled released acth containing microspheres
SE9200858L (sv) * 1992-03-20 1993-09-21 Kabi Pharmacia Ab Metod för framställning av pellets med fördröjd frisättning
ES2181691T5 (es) * 1992-06-11 2007-10-01 Alkermes Controlled Therapeutics, Inc. Sistema de distribucion de proteina eritropoyetina.
US5350584A (en) * 1992-06-26 1994-09-27 Merck & Co., Inc. Spheronization process using charged resins
JP2651320B2 (ja) * 1992-07-16 1997-09-10 田辺製薬株式会社 徐放性マイクロスフェア製剤の製造方法
FR2693905B1 (fr) * 1992-07-27 1994-09-02 Rhone Merieux Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues.
GB2273874A (en) * 1992-12-31 1994-07-06 Pertti Olavi Toermaelae Preparation of pharmaceuticals in a polymer matrix

Also Published As

Publication number Publication date
CA2123481A1 (en) 1994-11-16
JP3139913B2 (ja) 2001-03-05
BR9401968A (pt) 1994-12-13
PT101518B (pt) 2000-12-29
GB9310030D0 (en) 1993-06-30
ES2097083A1 (es) 1997-03-16
SE9401557D0 (sv) 1994-05-05
NO307403B1 (no) 2000-04-03
IT1269508B (it) 1997-04-01
CH688572A5 (fr) 1997-11-28
JPH072652A (ja) 1995-01-06
HU220617B1 (hu) 2002-03-28
DK171454B1 (da) 1996-11-04
LU88482A1 (fr) 1994-12-01
ITMI940931A0 (it) 1994-05-11
AT406017B (de) 2000-01-25
PT101518A (pt) 1995-03-01
SG46631A1 (en) 1998-02-20
FR2705232A1 (fr) 1994-11-25
FR2705232B1 (fr) 1995-08-25
CA2123481C (en) 2005-01-11
GB9409565D0 (en) 1994-07-06
IN182330B (OSRAM) 1999-03-20
HK1002831A1 (en) 1998-09-18
OA09939A (fr) 1994-11-15
IE940392A1 (en) 1994-11-16
ZA943316B (en) 1995-01-16
NO941810L (no) 1994-11-16
ES2097083B1 (es) 1997-12-01
CN1104557A (zh) 1995-07-05
FI942222A0 (fi) 1994-05-13
PL175780B1 (pl) 1999-02-26
DE4416812C2 (de) 2003-02-06
FI112915B (fi) 2004-02-13
TNSN94046A1 (fr) 1995-04-25
AU685094B2 (en) 1998-01-15
KR100341261B1 (ko) 2002-09-27
ITMI940931A1 (it) 1995-11-11
HUT67599A (en) 1995-04-28
NL9400795A (nl) 1994-12-01
GB2277915A (en) 1994-11-16
CN1050534C (zh) 2000-03-22
DZ1779A1 (fr) 2002-02-17
GB2277915B (en) 1997-10-29
SE9401557L (sv) 1994-11-16
RU2125869C1 (ru) 1999-02-10
DE4416812A1 (de) 1994-11-17
NZ260520A (en) 1994-12-22
BE1008323A3 (fr) 1996-04-02
AU6308494A (en) 1994-11-17
ATA98794A (de) 1999-06-15
NO941810D0 (no) 1994-05-13
DK54994A (da) 1994-11-16
HU9401412D0 (en) 1994-08-29
FI942222L (fi) 1994-11-16
SE519004C2 (sv) 2002-12-17
GR1002034B (en) 1995-10-31

Similar Documents

Publication Publication Date Title
MA26516A1 (fr) Tartrate d'un dipeptide substitue, procede pour sa preparation et compositions pharmaceutiques le contenant.
MA26415A1 (fr) Composes heterocycliques, procede pour la preparation et compositions pharmaceutiques les contenant
MA26420A1 (fr) Compositions pharmaceutiques mixtes pour le traitement de l'osteoporose, et procede pour leur preparation.
MA26536A1 (fr) Association de compositions pharmaceutiques d'atorvastatine et d'agents antihypertensifs, et procede pour leur preparation.
MA26471A1 (fr) Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26687A1 (fr) 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2504408B1 (fr) Procede de preparation de particules submicroscopiques, particules ainsi obtenues et compositions pharmaceutiques les contenant
MA26571A1 (fr) Derives d'acide hydroxamique, compositions pharmaceutiques les contenant et procede pour leur preparation
MA26430A1 (fr) 4 (3h)-quinazolinones 2,3-disubstituees nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26438A1 (fr) Derives 6,5-heterobicycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26508A1 (fr) Formulations pharmaceutiques contenant du variconazole, et procede pour leur preparation.
MA26424A1 (fr) Derives de 6-phenylpyridyl-2-amine, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2675382B1 (fr) Particules des substances biologiquement actives, procede pour leur preparation et compositions pharmaceutiques les contenant.
ZA965294B (en) Substituted 4-phenylaminothiazoles, their process of preparation and the pharmaceutical compositions containing them.
FR2665453B1 (fr) Polylactides purifies, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2739860B1 (fr) Complexes amphiphiles, procede pour leur preparation et compositions en renfermant
FR2751334B1 (fr) Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26519A1 (fr) Derives d'azetidinylpropylpiperidine, procede pour leur preparation et compositions pharmaceutiques les contenant.
MC1915A1 (fr) Procédés pour la préparation de 2',3'-didésoxynucléosides et de formulations pharmaceutiques en contenant
MA26417A1 (fr) Azetidines, procede pour leur preparation, et compositions pharmaceutiques les contenant
MA23194A1 (fr) Procede pour la preparation de particules preparees a sec, particules preparees a sec ainsi obtenues et compositions pharmaceutiques contenant de telles particules .
FR2773804B1 (fr) Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant
FR2663326B2 (fr) Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
MA26437A1 (fr) Derives de trans-piperazine-1-yl-spiro (cyclohexane-1,1'-isobenzofuranne), procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26708A1 (fr) Derive d'indole nouveau, procede pour sa preparation et compositions pharmaceutiques le contenant